The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis

Redox Biology

Volumn 1, Issue 1, 2013, Pages 145-152

  Spickett, Corinne M ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Anti HNE antibodies; HNE protein adducts; Hydroxyalkenal; Mass spectrometry; Neutral loss scanning; Redox signalling

Indexed keywords

4 HYDROXYNONENAL; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; GLUTATHIONE; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; 4-HYDROXY-2-NONENAL; ALDEHYDE;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; CLICK CHEMISTRY; DETOXIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIPID PEROXIDATION; MASS SPECTROMETRY; METABOLISM; MICHAEL ADDITION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; SHORT SURVEY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANALYTIC METHOD; CHEMICAL BINDING; CHEMICAL INTERACTION; CHEMICAL MODIFICATION; CORRELATIONAL STUDY; IMMUNOHISTOCHEMISTRY; REVIEW; TOXICITY TESTING; TOXIN ANALYSIS; CHEMISTRY;

ALDEHYDES; LIPID PEROXIDATION;

EID: 84878884100     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.01.007     Document Type: Review

References (86)

1. Schauenstein, E.; Esterbauer, H.; Jaag, G.; Taufer, M. The effect of aldehydes on normal and malignant cells. 1st report: hydroxy-octenal, a new fat-aldehyde. Monatshefte Fur Chemie 95:180-183; 1964.
2. Esterbauer, H.; Schaur, R. J.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology & Medicine 11:81-128; 1991.
3. Benedetti, A.; Comporti, M.; Esterbauer, H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochimica et Biophysica Acta 620:281-296; 1980.
4. Benedetti, A.; Comporti, M.; Fulceri, R.; Esterbauer, H. Cytotoxic aldehydes originating from the peroxidation of liver microsomal lipids. Identification of 4,5-dihydroxydecenal. Biochimica et Biophysica Acta 792:172-181; 1984.
5. Mlakar, A.; Spiteller, G. Previously unknown aldehydic lipid peroxidation compounds of arachidonic acid. Chemistry and Physics of Lipids 79:47-53; 1996.
6. Comporti, M. Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology. Free Radical Research 28:623-635; 1998.
7. Esterbauer, H.; Benedetti, A.; Lang, J.; Fulceri, R.; Fauler, G.; Comporti, M. Studies on the mechanism of formation of 4-hydroxynonenal during micro-somal lipid peroxidation. Biochimica et Biophysica Acta 876:154-166; 1986.
8. Poli, G.; Schaur, R. J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50:315-321; 2000.
9. Esterbauer, H., Zollner, H., Schaur, R. J., editors. Aldehydes formed by lipid peroxidation; mechanisms of formation, occurrence and determination. Boca Raton FL: CRC Press; 1990.
10. Pryor, W. A.; Porter, N. A. Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radical Biology & Medicine 8:541-543; 1990.
11. Loidl-Stahlhofen, A.; Hannemann, K.; Spiteller, G. Generation of alpha-hydroxyaldehydic compounds in the course of lipid peroxidation. Biochimica et Biophysica Acta 1213:140-148; 1994.
12. Takamura, H.; Gardner, H. W. Oxygenation of (3Z)-alkenal to (2E)-4-hydroxy-2-alkenal in soybean seed (Glycine max L.). Biochimica et Biophysica Acta 1303:83-91; 1996.
13. Kaur, K.; Salomon, R. G.; O'Neil, J.; Hoff, H. F. Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins. Chemical Research in Toxicology 10:1387-1396; 1997.
14. Schneider, C.; Tallman, K. A.; Porter, N. A.; Brash, A. R. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. The Journal of Biological Chemistry 276:20831-20838; 2001.
15. Schneider, C.; Porter, N. A.; Brash, A. R. Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. The Journal of Biological Chemistry 283:15539-15543; 2008.
16. Liu, W.; Porter, N. A.; Schneider, C.; Brash, A. R.; Yin, H. Formation of 4-hydroxynonenal from cardiolipin oxidation: intramolecular peroxyl radical addition and decomposition. Free Radical Biology & Medicine 50:166-178; 2011.
17. Gu, X.; Salomon, R. G. Fragmentation of a linoleate-derived gamma-hydro-peroxy-alpha,beta-unsaturated epoxide to gamma-hydroxy- and gamma-oxo-alkenals involves a unique pseudo-symmetrical diepoxycarbinyl radical. Free Radical Biology & Medicine 52:601-606; 2012.
18. Alary, J.; Gueraud, F.; Cravedi, J. P. Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Molecular Aspects of Medicine 24:177-187; 2003.
19. Siems, W. G.; Pimenov, A. M.; Esterbauer, H.; Grune, T. Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in thymocytes as an effective secondary antioxidative defense mechanism. Journal of Biochemistry (Tokyo) 123:534-539; 1998.
20. Balogh, L. M.; Atkins, W. M. Interactions of glutathione transferases with 4-hydroxynonenal. Drug Metabolism Reviews 43:165-178; 2011.
21. Alary, J.; Debrauwer, L.; Fernandez, Y.; Paris, A.; Cravedi, J. P.; Dolo, L.; Rao, D.; Bories, G. Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats. Chemical Research in Toxicology 11:1368-1376; 1998.
22. Gueraud, F.; Peiro, G.; Bernard, H.; Alary, J.; Creminon, C.; Debrauwer, L.; Rathahao, E.; Drumare, M. F.; Canlet, C.; Wal, J. M.; Bories, G. Enzyme immunoassay for a urinary metabolite of 4-hydroxynonenal as a marker of lipid peroxidation. Free Radic. Biol. Med. 40:54-62; 2006.
23. Srivastava, S.; Chandra, A.; Wang, L. F.; Seifert Jr W. E.; DaGue, B. B.; Ansari, N. H.; Srivastava, S. K.; Bhatnagar, A. Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. The Journal of Biological Chemistry 273:10893-10900; 1998.
24. Hill, B. G.; Awe, S. O.; Vladykovskaya, E.; Ahmed, Y.; Liu, S. Q.; Bhatnagar, A.; Srivastava, S. Myocardial ischaemia inhibits mitochondrial metabolism of 4-hydroxy-trans-2-nonenal. The Biochemical Journal 417:513-524; 2009.
25. Esterbauer, H.; Zollner, H. Methods for determination of aldehydic lipid peroxidation products. Free Radical Biology & Medicine 7:197-203; 1989.
26. Yan, L. J.; Forster, M. J. Chemical probes for analysis of carbonylated proteins: a review. Journal of Chromatography B: Analytical Technologies in the Biome-dical and Life Sciences 879:1308-1315; 2011.
27. Selley, M. L. Determination of the lipid peroxidation product (E)-4-hydroxy-2-nonenal in clinical samples by gas chromatography negative-ion chemical ionisation mass spectrometry of the O-pentafluorobenzyl oxime. Journal of Chromatography B 691:263-268; 1997.
28. Van kuijk, F. J. G. M.; Siakotos, A. N.; Fong, L. G.; Stephens, R. J.; Thomas, D. W. Quantitative measurement of 4-hydroxyalkenals in oxidized low-density-lipoprotein by gas-chromatography mass-spectrometry. Analytical Biochemistry 224:420-424; 1995.
29. Gioacchini, A. M.; Calonghi, N.; Boga, C.; Cappadone, C.; Masotti, L.; Roda, A.; Traldi, P. Determination of 4-hydroxy-2-nonenal at cellular levels by means of electrospray mass spectrometry. Rapid Communications in Mass Spectro-metry 13:1573-1579; 1999.
30. Zanardi, E.; Jagersma, C. G.; Ghidini, S.; Chizzolini, R. Solid phase extraction and liquid chromatography-tandem mass spectrometry for the evaluation of 4-hydroxy-2-nonenal in pork products. Journal of Agricultural and Food Chemistry 50:5268-5272; 2002.
31. Aldini, G.; Dalle-Donne, I.; Colombo, R.; Maffei Facino, R.; Milzani, A.; Carini, M. Lipoxidation-derived reactive carbonyl species as potential drug targets in preventing protein carbonylation and related cellular dysfunction. ChemMed-Chem 1:1045-1058; 2006.
32. Carini, M.; Aldini, G.; Facino, R. M. Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins. Mass Spectrometry Reviews 23:281-305; 2004.
33. Uchida, K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Progress in Lipid Research 42:318-343; 2003.
34. Fritz, K. S.; Petersen, D. R. Exploring the biology of lipid peroxidation-derived protein carbonylation. Chemical Research in Toxicology 24:1411-1419; 2011.
35. Zhu, X.; Tang, X.; Anderson, V. E.; Sayre, L. M. Mass spectrometric characterization of protein modification by the products of nonenzymatic oxidation of linoleic acid. Chemical Research in Toxicology 22:1386-1397; 2009.
36. Rauniyar, N.; Prokai, L. Detection and identification of 4-hydroxy-2-nonenal Schiff-base adducts along with products of Michael addition using data-dependent neutral loss-driven MS3 acquisition: method evaluation through an in vitro study on cytochrome c oxidase modifications. Proteomics 9:5188-5193; 2009.
37. Tang, X.; Sayre, L. M.; Tochtrop, G. P. A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modification of cytochrome c. Journal of Mass Spectrometry: JMS 46:290-297; 2011.
38. Palinski, W.; Rosenfeld, M. E.; Yla-Herttuala, S.; Gurtner, G. C.; Socher, S. S.; Butler, S. W.; Parthasarathy, S.; Carew, T. E.; Steinberg, D.; Witztum, J. L. Low density lipoprotein undergoes oxidative modification in vivo. Proceedings of the National Academy of Sciences of the United States of America 86: 1372-1376; 1989.
39. Steinbrecher, U. P.; Fisher, M.; Witztum, J. L.; Curtiss, L. K. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetyla-tion, or carbamylation: generation of antibodies specific for derivatized lysine. Journal of Lipid Research 25:1109-1116; 1984.
40. Palinski, W.; Yla-Herttuala, S.; Rosenfeld, M. E.; Butler, S. W.; Socher, S. A.; Parthasarathy, S.; Curtiss, L. K.; Witztum, J. L. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis (Dallas, Tex) 10:325-335; 1990.
41. Jurgens, G.; Ashy, A.; Esterbauer, H. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein(a) and very-low-density lipoprotein-use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein. Biochemical Journal 265:605-608; 1990.
42. Chen, Q.; Esterbauer, H.; Jurgens, G. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination. The Biochemical Journal 288:249-254; 1992 Pt 1.
43. Uchida, K.; Szweda, L. I.; Chae, H. Z.; Stadtman, E. R. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 90:8742-8746; 1993.
44. Toyokuni, S.; Miyake, N.; Hiai, H.; Hagiwara, M.; Kawakishi, S.; Osawa, T.; Uchida, K. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Letters 359:189-191; 1995.
45. Uchida, K.; Itakura, K.; Kawakishi, S.; Hiai, H.; Toyokuni, S.; Stadtman, E. R. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Archives of Biochemistry and Biophysics 324:241-248; 1995.
46. Waeg, G.; Dimsity, G.; Esterbauer, H. Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radical Research 25:149-159; 1996.
47. Itakura, K.; Oya-Ito, T.; Osawa, T.; Yamada, S.; Toyokuni, S.; Shibata, N.; Kobayashi, M.; Uchida, K. Detection of lipofuscin-like fluorophore in oxidized human low-density lipoprotein. 4-hydroxy-2-nonenal as a potential source of fluorescent chromophore. FEBS Letters 473:249-253; 2000.
48. Hartley, D. P.; Kroll, D. J.; Petersen, D. R. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal-and malondialdehyde-protein adducts. Chemical Research in Toxicology 10:895-905; 1997.
49. Cohn, J. A.; Tsai, L.; Friguet, B.; Szweda, L. I. Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: immunochemical detection in mitochondria exposed to oxidative stress. Archives of Biochemistry and Biophysics 328:158-164; 1996.
50. Akagawa, M.; Ito, S.; Toyoda, K.; Ishii, Y.; Tatsuda, E.; Shibata, T.; Yamaguchi, S.; Kawai, Y.; Ishino, K.; Kishi, Y.; Adachi, T.; Tsubata, T.; Takasaki, Y.; Hattori, N.; Matsuda, T.; Uchida, K. Bispecific abs against modified protein and DNA with oxidized lipids. Proceedings of the National Academy of Sciences of the United States of America 103:6160-6165; 2006.
51. Uchida, K.; Osawa, T.; Hiai, H.; Toyokuni, S. 4-Hydroxy-2-nonenal-trapping ELISA: direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins. Biochemical and Biophysical Research Communications 212:1068-1073; 1995.
52. Satoh, K.; Yamada, S.; Koike, Y.; Igarashi, Y.; Toyokuni, S.; Kumano, T.; Takahata, T.; Hayakari, M.; Tsuchida, S.; Uchida, K. A 1-hour enzyme-linked immunosorbent assay for quantitation of acrolein- and hydroxynonenal-modified proteins by epitope-bound casein matrix method. Analytical Biochemistry 270:323-328; 1999.
53. Borovic, S.; Rabuzin, F.; Waeg, G.; Zarkovic, N. Enzyme-linked immunosor-bent assay for 4-hydroxynonenal-histidine conjugates. Free Radical Research 40:809-820; 2006.
54. Kruman, I.; Bruce-Keller, A. J.; Bredesen, D.; Waeg, G.; Mattson, M. P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. The Journal of Meuroscience: The Official Journal of the Society for Neuroscience 17:5089-5100; 1997.
55. Eaton, P.; Li, J. M.; Hearse, D. J.; Shattock, M. J. Formation of 4-hydroxy-2-nonenal-modified proteins in ischaemic rat heart. The American Journal of Physiology 276:H935-943; 1999.
56. Butterfield, D. A.; Reed, T.; Sultana, R. Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogen-esis of Alzheimer's disease. Free Radical Research 45:59-72; 2011.
57. Smith, M. A.; Sayre, L. M.; Anderson, V. E.; Harris, P. L. R.; Beal, M. F.; Kowall, N.; Perry, G. Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. Journal of Histochemistry & Cytochemistry 46: 731-735; 1998.
58. Reed, T.; Perluigi, M.; Sultana, R.; Pierce, W. M.; Klein, J. B.; Turner, D. M.; Coccia, R.; Markesbery, W. R.; Butterfield, D. A. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiology of Disease 30:107-120; 2008.
59. Reed, T. T.; Pierce, W. M.; Markesbery, W. R.; Butterfield, D. A. Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD. Brain Research 1274:66-76; 2009.
60. Higdon, A. N.; Dranka, B. P.; Hill, B. G.; Oh, J. Y.; Johnson, M. S.; Landar, A.; Darley-Usmar, V. M. Methods for imaging and detecting modification of proteins by reactive lipid species. Free Radical Biology & Medicine 47: 201-212; 2009.
61. Landar, A.; Zmijewski, J. W.; Dickinson, D. A.; Le Goffe, C.; Johnson, M. S.; Milne, G. L.; Zanoni, G.; Vidari, G.; Morrow, J. D.; Darley-Usmar, V. M. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. American Journal of Physiology Heart and Circulatory Physiology 290:H1777-1787; 2006.
62. Vila, A.; Tallman, K. A.; Jacobs, A. T.; Liebler, D. C.; Porter, N. A.; Marnett, L. J. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chemical Research in Toxicology 21:432-444; 2008.
63. Doorn, J. A.; Petersen, D. R. Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chemical Research in Toxicology 15:1445-1450; 2002.
64. Liu, Z.; Minkler, P. E.; Sayre, L. M. Mass spectroscopic characterization of protein modification by 4-hydroxy-2-(E)-nonenal and 4-oxo-2-(E)-nonenal. Chemical Research in Toxicology 16:901-911; 2003.
65. Alderton, A. L.; Faustman, C.; Liebler, D. C.; Hill, D. W. Induction of redox instability of bovine myoglobin by adduction with 4-hydroxy-2-nonenal. Biochemistry 42:4398-4405; 2003.
66. Isom, A. L.; Barnes, S.; Wilson, L.; Kirk, M.; Coward, L.; Darley-Usmar, V. Modification of Cytochrome c by 4-hydroxy- 2-nonenal: evidence for histidine, lysine, and arginine-aldehyde adducts. Journal of the American Society for Mass Spectrometry 15:1136-1147; 2004.
67. Eliuk, S. M.; Renfrow, M. B.; Shonsey, E. M.; Barnes, S.; Kim, H. Active site modifications of the brain isoform of creatine kinase by 4-hydroxy-2-nonenal correlate with reduced enzyme activity: mapping of modified sites by Fourier transform-ion cyclotron resonance mass spectrometry. Chemical Research in Toxicology 20:1260-1268; 2007.
68. Ishii, T.; Tatsuda, E.; Kumazawa, S.; Nakayama, T.; Uchida, K. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phosphate dehydro-genase. Biochemistry 42:3474-3480; 2003.
69. D'Souza, A.; Kurien, B. T.; Rodgers, R.; Shenoi, J.; Kurono, S.; Matsumoto, H.; Hensley, K.; Nath, S. K.; Scofield, R. H. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Medical Genetics 9:62; 2008.
70. Carbone, D. L.; Doorn, J. A.; Kiebler, Z.; Petersen, D. R. Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chemical Research in Toxicology 18:1324-1331; 2005.
71. Grimsrud, P. A.; Picklo Sr M. J.; Griffin, T. J.; Bernlohr, D. A. Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Molecular & Cellular Proteomics: MCP 6:624-637; 2007.
72. Madian, A. G.; Regnier, F. E. Proteomic identification of carbonylated proteins and their oxidation sites. Journal of Proteome Research 9:3766-3780; 2010.
73. Madian, A. G.; Regnier, F. E. Profiling carbonylated proteins in human plasma. Journal of Proteome Research 9:1330-1343; 2010.
74. Mendez, D.; Hernaez, M. L.; Kamali, A. N.; Diez, A.; Puyet, A.; Bautista, J. M. Differential carbonylation of cytoskeletal proteins in blood group O erythro-cytes: potential role in protection against severe malaria. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 12:1780-1787; 2012.
75. Chavez, J. D.; Wu, J. Y.; Bisson, W.; Maier, C. S. Site-specific proteomic analysis of lipoxidation adducts in cardiac mitochondria reveals chemical diversity of 2-alkenal adduction. Journal of Proteomics 74:2417-2429; 2011.
76. Rauniyar, N.; Stevens, S. M.; Prokai-Tatrai, K.; Prokai, L. Characterization of 4-hydroxy-2-nonenal-modified peptides by liquid chromatography-tandem mass spectrometry using data-dependent acquisition: neutral loss-driven MS3 versus neutral loss-driven electron capture dissociation. Analytical Chemistry 81:782-789; 2009.
77. Rauniyar, N.; Prokai-Tatrai, K.; Prokai, L. Identification of carbonylation sites in apomyoglobin after exposure to 4-hydroxy-2-nonenal by solid-phase enrichment and liquid chromatography-electrospray ionization tandem mass spectrometry. Journal of Mass Spectrometry: JMS 45:398-410; 2010.
78. Rauniyar, N.; Prokai, L. Isotope-coded dimethyl tagging for differential quantification of posttranslational protein carbonylation by 4-hydroxy-2-nonenal, an end-product of lipid peroxidation. Journal of Mass Spectrometry 46:976-985; 2011.
79. Poli, G.; Biasi, F.; Leonarduzzi, G. 4-hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Molecular Aspects of Medicine 29:67-71; 2008.
80. Poli, G.; Schaur, R. J.; Siems, W. G.; Leonarduzzi, G. 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Medicinal Research Reviews 28:569-631; 2008.
81. Forman, H. J.; Fukuto, J. M.; Miller, T.; Zhang, H.; Rinna, A.; Levy, S. The chemistry of cell signalling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Archives of Biochemistry and Biophysics 477:183-195; 2008.
82. Castello, L.; Marengo, B.; Nitti, M.; Froio, T.; Domenicotti, C.; Biasi, F.; Leonarduzzi, G.; Pronzato, M. A.; Marinari, U. M.; Poli, G.; Chiarpotto, E. 4-hydroxynonenal signalling to apoptosis in isolated rat hepatocytes: the role of PKC-delta. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids 83-93:2005; 1737.
83. Noguchi, N. Role of oxidative stress in adaptive responses in special reference to atherogenesis. Journal of Clinical Biochemistry and Nutrition 43:131-138; 2008.
84. Chaudhary, P.; Sharma, R.; Sharma, A.; Vatsyayan, R.; Yadav, S.; Singhal, S. S.; Rauniyar, N.; Prokai, L.; Awasthi, S.; Awasthi, Y. C. Mechanisms of 4-hydroxy-2-nonenal induced pro- and anti-apoptotic signalling. Biochemistry 49: 6263-6275; 2010.
85. Menini, S.; Iacobini, C.; Ricci, C.; Scipioni, A.; Blasetti Fantauzzi, C.; Giaccari, A.; Salomone, E.; Canevotti, R.; Lapolla, A.; Orioli, M.; Aldini, G.; Pugliese, G. D-Carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation. British Journal of Pharmacology 166:1344-1356; 2012.
86. Aldini, G.; Dalle-Donne, I.; Facino, R. M.; Milzani, A.; Carini, M. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Medicinal Research Reviews 27:817-868; 2007.